🇺🇸 Vir Biotechnology, Inc.VIR
Get Vir Biotechnology, Inc. filings on Telegram the moment they are published.
Follow Vir Biotechnology, Inc. on TelegramOne tap starts your 30-day free trial. No card needed.
Subject: 8-K Items 3.02, 8.01, 9.01
Overview: Entered a collaboration with Gilead Sciences to develop three T-cell engagers, with up to $135 million in upfront/near-term payments and $1.74 billion in milestones.
Source: SEC EDGAR · Original filing
Get filings like this in Telegram the moment they are published — for the companies you follow.
Start 30-day trial About Finterest